LMB contribution towards UK bioscience success illuminated

The stories behind three great LMB successes are highlighted in a report by the UK BioIndustry Association (BIA). Humira, the first fully humanised antibody and one of the worlds top selling drugs (pages 3-4), Lemtrada (CAMPATH) treatment for Multiple Sclerosis (pages 5-6) and the Stabilised GPCR StaR® technology which enables determination of receptor structures (pages 11-12) all came from work carried out at the LMB. To read about these stories and others, please download the pdf “Celebrating UK Bioscience“.